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Introduction
Chronic recurrent multifocal osteomyelitis (CRMO) is
an autoinflammatory bone disorder that manifests as
recurrent flares of inflammatory bone pain, related to
one or more foci of nonbacterial osteomyelitis. Patients
may present with low grade fever and modest elevation
of the erythrocyte sedimentation rate (ESR), C-reactive
protein (CRP) and white blood cell counts (WBC). We
describe two cases of chronic recurrent multifocal osteo-
myelitis with high fever and pronounced elevation of
inflammatory parameters.
Methods
The first case was an 8-year-old boy presenting to the
hospital with polyarticular pain, limping, fever, decreased
appetite, weight loss and fatigue. CRP was 171 mg/l, ESR
81 mmh, WBC 16.5 G/l with 85% of neutrophils. We
could exclude an infectious origin and suspected systemic
onset juvenile idiopathic arthritis (SoJIA).
The patient responded well to NSAIDs, and after dis-
continuation he showed a stiff neck without history of
trauma. Cervical MRI showed C2 and C4 vertebral com-
paction with bone oedema. Total body MRI showed right
distal femoral, right distal fibular and left acetabular
enhancement. CRMO was suspected and a fibular biopsy,
performed to rule out a tumour, showed fibrous remodel-
ling of the bone, supporting the diagnosis of CRMO.
NSAIDs were restarted with progressive improvement. A
follow up MRI 6 months later showed decrease of cervical
vertebrae oedema.
The second case was a 7-year-old boy with 2 weeks of
high fever, decreased appetite, and weight loss without
perspiration or chills. Blood parameters showed CRP 105
mg/l, ESR 72 mm/h and thrombocytosis 651 G/l. WBC
was normal. Infectious and onco-haematological origines
were excluded. A few days later he complained about left
wrist pain. An MRI showed a significant periosteal reac-
tion of the two bones of the forearm, associated with soft
tissue involvement. Bone scintigraphy revealed hypercap-
tation of both forearms suggesting CRMO. Bone biopsy
showed no inflammation or other abnormalities.
Under NSAIDs, the patient did not improve and the
biological parameters remained elevated. Because of the
persistence of high fever and significant systemic inflam-
mation a treatment with Anakinra, interleukin-1 (IL-1)
receptor antagonist, was started, and induced rapid
improvement of both bone pain and fever. When Ana-
kinra was discontinued, inflammatory parameters
increased again, without fever or other symptoms. A total
body MRI was performed and showed multiple symmetri-
cal enhancements in different skeletal segments.
Conclusion
The two cases described showed an atypical presentation
of CRMO, with high fever and increased inflammatory
parameters suggesting a SoJIA. Interestingly, the second
case responded to IL-1 blockade, suggesting a role for this
cytokine in the disease. Another genetic syndrome, DIRA
(deficiency of interleukin-1 receptor antagonist), presents
with a similar phenotype to CRMO and could suggest an
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